2021 Italy Clinical Chemistry Market Assessment-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 55 Tests, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

January 2021 | | ID: 2E1147B84126EN
Venture Planning Group

Abstracts

LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the clinical chemistry market during the next five years. The report is available by section, and can be customized to specific information needs and budget. The report explores future trends in the clinical chemistry market; provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.

The report provides five-year volume and sales forecasts for 55 clinical chemistry assays, including controls, calibrators and consumables.

Rationale

The clinical chemistry market is undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

Market Overview

• Estimates of facilities performing clinical chemistry and immunodiagnostic tests.
• Test volume and sales projections.

Strategic Recommendations

• New product development opportunities with significant market appeal.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.

Market Segmentation Analysis

• Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers.
• Test volume and sales forecasts for 55 clinical chemistry assays, by market segment:
  • Hospitals
  • Commercial/Private Laboratories

Tests Analyzed in the Report

Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), Calcitonin, Calcium, Carbon Dioxide/Bicarbonate, Cardio hs CRP, Chloride, Cholesterol, Cholinesterase, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Cystatin C, Ferritin, Fructosamine, GGT, Glucose, HDL Cholesterol, Homocysteine, hs-CRP, Insulin, Iron, Iron (Total Binding Capacity), Iron (Unsaturated Binding Capacity), LDH, LDL Cholesterol, LDL Cholesterol Direct, Lipase, Lipoprotein a, Magnesium, Microalbumin, Myoglobin, NT-proBNP, Phosphorus, Potassium, Sodium, ST2, Total Protein, Transferrin, Triglycerides, Troponin, Uric Acid

Current and Emerging Products

• Analysis of current and emerging clinical chemistry tests.
• Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.

Technology Review

• Assessment of current and emerging technologies, and their potential market applications.
• Comprehensive lists of companies developing or marketing new technologies and products by test.

Competitive Assessments

Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Contents

I. INTRODUCTION

II. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

III. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

IV. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets

V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VI. MARKET AND TECHNOLOGY OVERVIEW

A. Selected Tests Clinical Significance and Diagnostic Procedures
  1. Albumin
  2. Alkaline Phosphatase
  3. ALT/SGPT
  4. Ammonia
  5. Amylase
  6. AST/SGOT
  7. Bilirubin, Total
  8. Blood Gases
  9. Blood Urea Nitrogen (BUN)
  10. Calcium
  11. Cardio CRP
  12. Cholesterol
  13. Cholinesterase
  14. CRP
  15. Creatinine
  16. Electrolytes
    a. Carbon Dioxide/Bicarbonate
    b. Chloride
    c. Potassium
    d. Sodium
  17. Ferritin
  18. Fructosamine
  19. Gamma-Glutamyl Transpeptidase (GGT)
  20. Glucose
  21. High Density Lipoprotein (HDL)
  22. Homocysteine
  23. Iron
  24. Lactate Dehydrogenase (LDH)
  25. Magnesium
  26. Phosphorus
  27. Protein
  28. Triglycerides
  29. Uric Acid
  30. Troponin
B. Clinical Chemistry Instrumentation Review: operating characteristics and features of high-, medium-, and low-volume/POC analyzers
C. Major Clinical Chemistry Technologies and Their Potential Applications
  1. Monoclonal and Polyclonal Antibodies
  2. Immunoassays
  3. Tandem Mass Spec
  4. IT and Automation
  5. Dry Chemistry
  6. Biosensors

VII. CLINICAL CHEMISTRY MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Instrument, Reagent Sales and Market Shares

VIII. COMPETITIVE ASSESSMENTS

Abbott Laboratories
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio
Grifols
Instrumentation Laboratory/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako